News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MicroIslet Inc. (MII) Announces Management Change and Receives Working Capital Loan


1/25/2008 11:08:44 AM

SAN DIEGO--(BUSINESS WIRE)--MicroIslet Inc., (OTCBB: MIIS, http://www.microislet.com), a biotechnology company engaged in the development and commercialization of transplantation therapies for diabetes, announced that Jonathan R. T. Lakey, PhD is no longer the Company’s president and chief scientific officer. Dr. Lakey remains a member of the Board of Directors.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES